Swiss Biopharma Lumavita AG Raises $5.53 Million in New Series A Funding
6/19/2009 8:44:02 AM
pehub.com -- Lumavita AG, a Swiss developer of anti-infectives for women’s health, has raised CHF 6 million ($5.53m) in new Series A funding. The round total is now CHF 24 million ($22m). HealthCap led the tranche, and was joined by return backer Endeavour Vision.
comments powered by